Order Lipitor, [This review was originally posted on Sept. 23, 2011, at the Nieman Journalism Lab.]

Facebook ramps its sharing up even further: We had been hearing all week about a big announcement Facebook would be making this Thursday at its annual conference — about how it would mark the social network's rebirth and leave the competition in the dust. So here's what we got (in a handy roundup from Gizmodo): A Twitter-like mini-feed called Ticker (meant to make the News Feed look more like "your own personal newspaper"), apps on Facebook's Open Graph, sharing music and games through integration with services like the music player Spotify, No prescription Lipitor online, and Timeline, essentially a one-page Facebook life story.

It's pretty clear what Facebook's goal is with all of this: Put charitably, as Wired's Mike Isaac did, it's "allowing for the Facebook page to be a sort of one-stop shop, scooping up all of your activities and displaying them in one grand, blue and white frame." Put more skeptically, as the New Yorker's Nicholas Thompson did, is Lipitor addictive, Facebook wants to eat up a large chunk of the Internet, which has some real consequences: "The more our online lives take place on Facebook, the more we depend on the choices of the people who run the company—what they think about privacy, how they think we should be able to organize our friends, what they tell advertisers (and governments) about what we do and what we buy."

Tom Foremski of Silicon Valley Watcher made the point a different way, arguing that Facebook is trying to combat the natural slowdown in how much we're willing to share online by making it more frictionless and ubiquitous. Lipitor alternatives, Reactions were similar in displaying two sides of the same coin: The ability to pull together a lot of old social information into a single Timeline was either "something a lot of users wanted without much of a voice asking for it" (ZDNet's Rachel King) or a fix to "a problem absolutely no one was clamoring about" (Gawker's Adrian Chen). We'll get more of a sense of which side is more accurate over the next several months, Order Lipitor.

—

Facebook meets news apps: Another one of the changes announced by Facebook on Thursday was the addition of several new Facebook-based news apps, the first of which was the Wall Street Journal's WSJ Social, unveiled on Tuesday. (Others, like the Washington Post's and Yahoo's, were announced on Thursday.) As the Lab's Megan Garber explained, the app allows each user to edit their own stream of Journal material, is Lipitor safe, and to follow and rank others based on their editing.

As Forbes' Jeff Bercovici pointed out, the app seems to serve both the Journal's and Facebook's interests quite nicely: It keeps people's news consumption and interaction within Facebook, but allows the Journal to sell its own ads within the app and keep the money. (Facebook gets everything for the ads outside the app.)

There were questions about the app — Adweek's Dylan Byers wondered how fond people would be of an app that curates content from only one source, and GigaOM's Mathew Ingram questioned how well the socially oriented app would work with a hard paywall, Herbal Lipitor, and more generally, whether it's wise for news organizations to leave so much of their user interaction inside Facebook.

—

AOL's struggles and the future of online content: The AOL/TechCrunch saga Order Lipitor, seems to be (mercifully) winding down this week — the last real drama took place late last week, when one TechCrunch writer, Paul Carr, quit with a scorched-earth post directed at new editor Erick Schonfeld, and Schonfeld disputed his claims. But the bad news continues to roll in for AOL: The sales director for its hyperlocal news project, Patch, left — the second top AOL ad exec to bolt in the past month. Business Insider reported that AOL may lose $30 million on Patch this year. And AOL's prospects as a content-based company in general don't look rosy, as paidContent's Robert Andrews pointed out, online Lipitor without a prescription, looking at the declining revenues for AOL Europe once it dropped Internet access from its business model.

AOL execs remain positive in the face of all the bad news: Arianna Huffington said her Huffington Post's merger with AOL has been a boon for both HuffPo and Patch, thanks to the new synergies between the two operations. On the advertising side, AOL CEO Tim Armstrong said he hopes to catch Microsoft and Google in online display ads, a tall task, Order Lipitor.

Outside the company, of course, skeptics still abound. Where can i find Lipitor online, Bloomberg Businessweek's Peter Burrows declared AOL and its fellow web portal Yahoo dead companies walking, saying they "have tried to live by Old Media rules while masquerading as New Media powerhouses." And at Adweek, Michael Wolff pointed to AOL and Yahoo's struggles as evidence that online content can't sustain a business model. The only content that can still do that, he said, is TV or video: "What still works, what advertisers and audiences still seek, is superexpensive content."

—

Netflix's big split: It wasn't related to journalism per se, Lipitor pictures, but the big story at the intersection of media and tech this week was the announcement of Netflix's split into two businesses — one for streaming video online, and a new one, Qwikster, to continue its DVD-by-mail service. The change was welcomed by approximately no one: Not users or investors, as the New York Times reported, Buy generic Lipitor, not analysts like Business Insider's Henry Blodget (who said it's bad for customers) and paidContent's Robert Andrews (who said it's bad for business), and not the Oatmeal's Matthew Inman, who summed up the head-scratching nature of the move as well as anyone. Order Lipitor, Of course, Netflix had to have a reason for doing this, and there were several popular guesses, rounded up well by Tim Carmody of Wired. As Carmody explained, there are two main theories: 1) Separating DVDs and streaming makes it easier and cheaper for Netflix to negotiate rights with Hollywood (best articulated by venture capitalist Bill Gurley), and 2) Netflix wants to let its DVD business die in peace, without taking streaming down with it (argued in two posts by tech writer Dan Frommer). Along the lines of the latter theory, rx free Lipitor, GigaOM's Mathew Ingram likened Netflix's situation to the news business and wondered who would be the first newspaper company to spin off its print product from its digital side.

—

The News Corp. scandal and a press freedom threat: It's been a couple of months since News Corp.'s phone-hacking scandal was making big headlines, but the problems stemming from it continue to spread week by week. Deadline New York's David Lieberman looked at some of the financial signs indicating that the fallout may not be isolated to News Corp.'s British newspaper division, Order Lipitor. This week, a couple of aspects of the scandal heated up as another wound down: News Corp. Lipitor over the counter, is expected to settle its highest-profile hacking case (with the family of a murdered 12-year-old girl) for $4.7 million, while the U.S. Justice Department reportedly began asking the company for information in its investigation into bribery charges, and new allegations of hacking into a former government official's voicemail emerged.

Meanwhile, apart from News Corp., the story briefly sparked a press freedom fight when Scotland Yard invoked an espionage law to threaten the Guardian to give up its anonymous sources on one of the hacking cases. Order Lipitor, Journalists across Britain, including some from competitors like the Daily Mail, rose up to defend the Guardian, and within a few days, police dropped their threat. The backlash was strong enough that members of Parliament will question one of Scotland Yard's top officials over the plan, about Lipitor.

—

Reading roundup: Tons of other little things going on this week. Here's a quick tour:

— Some interesting media fallout from WikiLeaks' recent diplomatic cable release: Al Jazeera's news director resigned after the cables showed that he had modified the network's Iraq war coverage based on pressure from the U.S. This, of course, raised questions about Al Jazeera's independence and credibility. Elsewhere, British journalism thinker Charlie Beckett talked about what WikiLeaks can tell us about where news is headed, Order Lipitor. Buy Lipitor without a prescription, — Though its changes were trumped by Facebook, Google+ unveiled several new features and announced that it's open to everyone. J-prof Dan Reimold declared the new social network dead, but Wired's Tim Carmody explained how Google+'s changes are meant to change that.

— The Washington Post's Monica Hesse wrote a thought-provoking piece on journalists' tendency to obsess with things happening on social networks, leading to insights that ... aren't that insightful. If you're interested in using social media in a way that's actually worthwhile, fast shipping Lipitor, Poynter's Mallary Jean Tenore has a good guide to ways journalists can use Twitter before, during, and after reporting a story.

— At Silicon Valley Watcher, Matthew Buckland did a fascinating Q&A with Wired editor Chris Anderson — the first half on the decline of the open web, and the second on what journalism is now. Lipitor steet value, — This week's most interesting piece of media-related research comes from NYU's Tim Libert, who looked at thousands of comments about the online hacking group LulzSec, finding that the discourse indicated that the group is "in the position of villain rather than the champion of the people’s rights, as they would presumably like to be seen."

— Finally, the AP's Jonathan Stray wrote a stirring piece on what it would look like if we merged journalism with "maker culture," concluding, "This is a theory of civic participation based on empowering the people who like to get their hands dirty tinkering with the future. Maybe that’s every bit as important as informing voters or getting politicians fired.".

Similar posts: Zoloft For Sale. Purchase Cephalexin. Order Glucophage. Low dose Zoloft. Lipitor duration. Zoloft pictures.
Trackbacks from: Order Lipitor. Order Lipitor. Order Lipitor. Generic Lipitor. Taking Lipitor. Where to buy Lipitor.

[This review was originally posted at the Nieman Journalism Lab Cipro Cost, on Oct. 22, 2010.]

The value of hard news online: Perfect Market, a company that works on monetizing news online, released a study this week detailing the value of this summer's most valuable stories. The study included an interesting finding: The fluffy, celebrity-driven stories that generate so much traffic for news sites are actually less valuable to advertisers than relevant hard news. The key to this finding, purchase Cipro for sale, The New York Times reported, is that news stories that actually affect people are easier to sell contextual advertising around — and that kind of advertising is much more valuable than standard banner ads.

As Advertising Age pointed out, a lot of this goes back to keyword ads and particularly Google AdSense; a lot of, say, mortgage lenders and immigration lawyers are doing keyword advertising, Australia, uk, us, usa, and they want to advertise around subjects that deal with those issues. In other words, stories that actually mean something to readers are likely to mean something to advertisers too, Cipro Cost.

But the relationship isn't quite that simple, said GigaOM's Mathew Ingram. Advertisers don't just want to advertise on pages about serious subjects; they want to advertise on pages about serious subjects that are getting loads of pageviews — and you get those pageviews by also writing about the Lindsey Lohans of the world. SEOmoz' s Rand Fishkin had a few lingering questions about the study, and the Lab's Megan Garber took the study as a cue that news organizations need to work harder on "making their ads contextually relevant to their content."

—

The Times Co.'s paywall surprise: The New York Times Co. released its third-quarter earnings statement (your summary: print down, digital up, overall meh), and the Awl's Choire Sicha put together a telling graph that shows how The Times has scaled down its operation while maintaining at least a small profit, Cipro natural. Sicha also noted that digital advertising now accounts for a third of The Times' total revenue, which has to be an relatively encouraging sign for the company.

Times Co. Cipro Cost, CEO Janet Robinson talked briefly and vaguely about the company's paid-content efforts, led by The Times' own planned paywall and the Boston Globe's two-site plan. But what made a few headlines was the fact that the company's small Massachusetts paper, The Telegram & Gazette, actually saw its number of unique visitors increase after installing a paywall in August. Cheap Cipro, Peter Kafka of All Things Digital checked the numbers out with comScore and offered a few possible reasons for the bump (maybe a few Google- or Facebook-friendly stories, or a seasonal traffic boost).

The Next Web's Chad Catacchio pushed back against Kafka's amazement, pointing out that the website remains free to print subscribers, which, he says, probably make up the majority of the people interested in visiting the site of a fairly small community paper like that one. Catacchio called the Times Co.'s touting of the paper's numbers a tactic to counter the skepticism about The Times' paywall, order Cipro no prescription, when in reality, he said, "this is completely apples and oranges."

—

WikiLeaks vs. the world: The international leaking organization WikiLeaks has kept a relatively low profile since it dropped 92,000 pages of documents on the war in Afghanistan in July, but Spencer Ackerman wrote at Wired that WikiLeaks is getting ready to release as many as 400,000 pages of documents on the Iraq War as soon as next week, as two other Wired reporters looked at WikiLeaks' internal conflict and the ongoing "scheduled maintenance" of its site, Cipro Cost. WikiLeaks editor Julian Assange responded by blasting Wired via Twitter, and Wired issued a defense.

One of the primary criticisms of WikiLeaks after their Afghanistan release was that they were putting the lives of American informants and intelligence agents at risk by revealing some of their identities. Cipro online cod, But late last week, we found out about an August memo by Defense Secretary Robert Gates acknowledging that no U.S. intelligence sources were compromised by the July leak. Salon's Glenn Greenwald documented Cipro Cost, the numerous times government officials and others in the media asserted exactly the opposite.

Greenwald asserted that part of the reason for the government's rhetoric is its fear of damage that could be caused by WikiLeaks future leaks, and sure enough, it's already urging news organizations not to publish information from WikiLeaks' Iraq documents. At The Link, Nadim Kobeissi wrote an interesting account of the battle over WikiLeaks so far, Cipro alternatives, characterizing it as a struggle between the free, open ethos of the web and the highly structured, hierarchical nature of the U.S. government. "No nation has ever fought, or even imagined, a war with a nation that has no homeland and a people with no identity, Cipro from canadian pharmacy, " Kobeissi said.

—

Third-party plans at Yahoo and snafus at Facebook: An interesting development that didn't get a whole lot of press this week: The Wall Street Journal reported that Yahoo will soon launch Y Connect, a tool like Facebook Connect that will put widgets on sites across the web that allow users to log in and interact at the sites under their Yahoo ID. PaidContent's Joseph Tarkatoff noted that Y Connect's success will depend largely on who it can convince to participate (The Huffington Post is in so far), Cipro Cost.

The Wall Street Journal also reported another story about social media and third parties this week that got quite a bit more play, when it revealed that many of the most popular apps on Facebook are transmitting identifying information to advertisers without users' knowledge. Search Engine Land's Barry Schwartz found the juxtaposition of the two stories funny, and while the tech world was abuzz, Michael Arrington of TechCrunch gave the report the "Move on, real brand Cipro online, nothing to see here" treatment.

—

An unplanned jump from NPR to Fox News: Another week, another prominent member of the news media fired for foot-in-mouth remarks: NPR commentator Juan Williams lost his job for saying on Fox News' The O'Reilly Factor that he gets nervous when he sees Muslims in traditional dress on airplanes. Within 24 hours of being fired, though, Williams had a full-time gig (and a pay raise) at Fox News. Williams has gotten into hot water with NPR Cipro Cost, before for statements he's made on Fox News, which led some to conclude that this was more about Fox News than that particular statement.

NPR CEO Vivian Schiller explained why Williams was booted (he engaged in non-fact-based punditry and expressed views he wouldn't express on NPR as a journalist, she said), but, of course, not everybody was pleased with the decision or its rationale. (Here's Williams' own take on the situation.) Much of the discussion was pretty politically oriented — New York's Daily Intel has a pretty good summary of the various perspectives — but there were several who weren't pleased with the firing along media-related lines, Cipro pharmacy. The American Journalism Review's Rem Rieder said the move came too hastily, and The Atlantic's Jeffrey Goldberg said he doesn't like the trend of news organizations firing reporters over statements about Muslims or Jews.

Glenn Greenwald of Salon didn't care for this firing in particular, but said if you cheered the firings of those other reporters, you can't rail about this one for consistency's sake. The Columbia Journalism Review's Joel Meares, meanwhile, argued that Williams' firing sent the wrong message, especially for a news outlet known for taking advantage of controversial moments as opportunities for civil discourse: "Say something off-key, and you’re silenced, Cipro Cost. Expect that from CNN, After Cipro, but we thought better of NPR."

—

Newsweek and The Daily Beast's deal dies: With rumors swirling of a merger between Newsweek and the online aggregator The Daily Beast, we were all ready to start calling the magazine TinaWeek or NewsBeast last weekend. But by Tuesday, The Wall Street Journal had reported that the talks were off. There were some conflicting reports about who broke off talks; the Beast's Tina Brown said she got cold feet, but new Newsweek owner Sidney Harman said both parties backed off. (Turns out it was former GE exec Jack Welch, an adviser on the negotiations, where to buy Cipro, who threw ice water on the thing.)

Business Insider's Joe Pompeo gave word of continued staff shuffling, and Zeke Turner of The New York Observer reported on the frosty relations between Newsweek staffers and Harman, as well as their disappointment that Brown wouldn't be coming to "just blow it up." The Wrap's Dylan Stableford wondered what Newsweek's succession plan for the 92-year-old Harman is. Cipro Cost, If Newsweek does fall apart, Slate media critic Jack Shafer said, that wouldn't be good news for its chief competitor, Time.

—

Reading roundup: We've got several larger stories that would have been standalone items in a less busy week, so we'll start with those.

— As Gawker first reported, What is Cipro, The Huffington Post folded its year-old Investigative Fund into the Center for Public Integrity, the deans of nonprofit investigative journalism. As Gawker pointed out, a lot of the fund's problems likely stemmed from the fact that it was having trouble getting its nonprofit tax status because it was only able to supply stories to its own site. The Knight Foundation, which recently gave the fund $1.7 million, handed it an additional $250,000 to complete the merger, canada, mexico, india.

— Nielsen released a study on iPad users with several interesting findings, including that books, TV and movies are popular content on it compared with the iPhone and nearly half of tablet owners describe themselves as early adopters. Also in tablet news, News Corp. delayed its iPad news aggregation app plans, and publishers might be worried about selling ads on a smaller set of tablet screens than the iPad, Cipro Cost.

— From the so-depressing-but-we-can't-stop-watching department: The Tribune Co.'s woes continue to snowball, with innovation chief Lee Abrams resigning late last week and CEO Randy Michaels set to resign late this week. Abrams issued a lengthy self-defense, and Chicago Tribune columnist John Kass defended his paper, too.

— J-prof Jay Rosen proposed what he calls the "100 percent solution"  — innovating in news trying to cover 100 percent of something. Paul Bradshaw liked the idea and began to build on it. Cipro Cost, — It's not a new debate at all, but it's an interesting rehashing nonetheless: Jeff Novich called Ground Report and citizen journalism useless tools that can never do what real journalism does. Megan Taylor and Spot.Us' David Cohn disagreed, strongly.

— Finally, former Los Angeles Times intern Michelle Minkoff wrote a great post about the data projects she worked on there and need to collaborate around news as data. As TBD's Steve Buttry wrote, "Each of the 5 W’s could just as easily be a field in a database. ... Databases give news content more lasting value, by providing context and relationships.".

Similar posts: Cipro For Sale. Cipro Dosage. Cipro Over The Counter. Cheap Zoloft. Generic Bactrim. Real brand Cipro online.
Trackbacks from: Cipro Cost. Cipro Cost. Cipro Cost. About Cipro. Cipro photos. Taking Cipro.

[This review was originally posted at the Nieman Journalism Lab Retin A Price, on Aug. 6, 2010.]

A newbie owner for Newsweek: This week was a big one for Newsweek: After being on the block since May, it was sold to Sidney Harman, a 92-year-old audio equipment mogul who's married to a Democratic congresswoman and owns no other media properties. The price: $1, plus the responsibility for Newsweek's liabilities, estimated at about $70 million, Retin A australia, uk, us, usa. The magazine's editor, Jon Meacham, is leaving with the sale, though he told Yahoo's Michael Calderone that he had decided in June to leave when Newsweek was sold, no matter who the new owners were. Harman's age and background and the low sale price made for quite a few biting jokes about the sale on Twitter, dutifully chronicled for us by Slate's Jack Shafer. Retin A forum, Harman didn't help himself out much by telling The New York Times he doesn't have a plan for Newsweek. In a pair of sharp articles, The Daily Beast painted a grim picture of what exactly Harman's getting himself into: The magazine's revenue dropped 38 percent from 2007 to 2009, and it's losing money in all of its core areas, Retin A Price. The Beast noted that with no other media properties, Harman doesn't have the synergy potential that the magazine's previous owners, The Washington Post Co., said Newsweek would need. So why was he chosen. Apparently, he genuinely cares about the publication, Retin A dose, and he's planning the least number of layoffs. (That, and the other bidders weren't too attractive, either.) PaidContent reported that his primary goal is to bring the magazine back to stability while he sets up a succession plan.

Everybody has ideas of what Harman should do with his newest plaything: MarketWatch's Jon Friedman wants to see Retin A Price, Newsweek drop the opinion-and-analysis approach that it's been aping from The Economist, as do several of the observers Politico talked to. (DailyFinance's Jeff Bercovici just wants Harman to make it a little less excruciatingly dull to read.) Two other Politico sources — new media guru Jeff Jarvis and former Newsweek Tumblr wizard Mark Coatney — want to see Newsweek shift away from a print focus and figure out how to be vital on the web. Media consultant Ken Doctor proposes pushing forward on tablet editions, Retin A pharmacy, multimedia and interacting with readers online as the future of the magazine. Jarvis also has some pieces of advice for magazines in general, urging to them to resist the iPad's siren song and get local, among other things.

Poynter's Rick Edmonds has the most intriguing idea for a new Newsweek — going nonprofit. That would likely require refining its editorial mission to a narrower focus on national and international affairs, with the pop culture analysis getting cut out, Edmonds says, but he believes Harman might actually be considering a nonprofit approach, Retin A Price. Ken Doctor suggests that with Harman's statements about the relative unimportance of turning a profit from the magazine, he's already blurring the lines between a for-profit and nonprofit organization.

Meanwhile, Retin A alternatives, others were busy speculating about who might be the editor to lead Newsweek into its next incarnation. Names thrown out included Newsweek International editor Fareed Zakaria, Newsweek.com editor Mark Miller, Slate Group editor Jacob Weisberg, and former Time editor and CNN CEO Walter Isaacson, Get Retin A, though Isaacson has taken himself out of consideration.

—

WikiLeaks and the need for context: WikiLeaks continued to see fallout from its unprecedented leak of 92,000 documents about the war in Afghanistan two weekends ago, with more cries for it to be shut down and its founder, Julian Assange, arrested, largely because its leak revealed the names of numerous Afghan informants to the U.S. Assange expressed regret Retin A Price, for those disclosures, and WikiLeaks said it's even asking for the Pentagon's help in identifying and redacting names of informants in its next document dump, though the Pentagon said they haven't heard from WikiLeaks yet. Not that the U.S, Retin A class. government hasn't been trying to make contact — it demanded the documents be returned(!), and agents detained a WikiLeaks researcher at customs and then tried to talk with him again at a hacking conference this week. An Australian TV station gave a fascinating inside look at Assange's life on the run, and Slate's Jack Shafer contrasted Assange's approach to leaking sensitive documents with the more government-friendly tack of traditional media outlets. WikiLeaks also had some news to report on the business-model side: It will begin collecting online micropayment donations through Flattr.

The ongoing discussion around WikiLeaks this week centered on what to do with the data it released, Retin A Price. The Tyndall Report provided a thorough roundup of how TV news organizations responded to the leak, Purchase Retin A, and several others pinned the rather ho-hum public reaction to the documents' contents on a lack of context provided by news organizations. Former Salon editor Scott Rosenberg said the leak provides a new opportunity to shed an antiquated scoop-based definition of news and bring the reality of the war home to people. In a smart post musing on the structure of the modern news story, the Lab's Megan Garber proposed an outlet dedicated solely to follow-up journalism, arguing that one of the biggest challenges in modern journalism is giving a sense of continuity to long-running stories. "What results is a flattening: the stories of our day, big and small, silly and significant, Retin A gel, ointment, cream, pill, spray, continuous-release, extended-release, are leveled to the same plane, occupying the same space, essentially, in the wobbly little IKEA bookshelf that is the modular news bundle," she wrote in a follow-up post.

Mashable also examined Retin A Price, (in nifty infographic form!) how WikiLeaks changes the whistleblower-journalist relationship, while NPR wondered whether WikiLeaks is on the source or journalist side of equation. And PBS' Idea Lab had something handy for news orgs: A guide to helping them think about how to handle large-scale document releases. Where can i find Retin A online, —

Tumblr trends upward: The social blogging service Tumblr got the New York Times profile treatment this week, as the paper focused on its growing popularity among news organizations who are trying to jump on it as the next big social media trend — a form of communication somewhere between Twitter and blogging. The article noted that several prominent media brands have Tumblr accounts, though many of them aren't doing much with theirs. Over at Mediaite, Anthony De Rosa, who runs the Tumblr account for the sports blog network SB Nation, said we can expect to see still more media outlets jump on the Tumblr bandwagon, buy Retin A no prescription, especially because it rewards smart media companies who have a distinctive voice.

New York's Nitasha Tiku tried to douse the hype, arguing that Mark Coatney's often-mentioned Tumblr success for Newsweek "wasn't thanks to the distribution channel on Tumblr, it was his irreverent, conversational style — and that will be difficult for the fresh-faced interns that old-media publications don't pay to run their Tumblrs." And Gawker gave us a graded rundown of traditional news orgs' Tumblr accounts, Retin A Price.

—

Two Internet freedom scares: From The Wall Street Journal and The New York Times this week came two stories that have had many people concerned about issues of freedom and the web. First, the Journal ran a series on the alarming amount of your online data and behavior that companies track on behalf of advertisers. Cluetrain Manifesto co-author Doc Searls argued that while the long-held ideal of intensely personal advertising is getting closer to reality, "the advertising business is going to crash up against a harsh fact: 'consumers' are real people, Real brand Retin A online, and most real people are creeped out by this stuff." Jeff Jarvis was much less moved by the Journal's reporting, mocking it as scaremongering that tells us nothing new. Salon's Dan Gillmor fell closer to Searls' outrage than to Jarvis' nonchalance, and media consultant Judy Sims said this series is a window into a complex future for display advertising, one that media executives need to become familiar with in a hurry. Retin A Price, Second, the Times unleashed an avalanche of commentary in the tech world with a report that Google and Verizon are moving toward an agreement that would allow companies to pay to get their content to web users more quickly, which would effectively end the passionately held open-Internet principle known as net neutrality. The FCC quickly suspended its closed-door net neutrality meetings, and despite denials from Google and Verizon (which Wired picked apart), a whole lot of whither-the-Internet concernensued, cheap Retin A no rx. I'm not going to dig too deeply into this story here (I'd rather wait until we have something concrete to opine about), but here are the best quick guides to what this might mean: J-prof Dan Kennedy, Salon's Dan Gillmor and ProPublica's Marian Wang.

—

Reading roundup: Just a couple of quick items this week:

— Thanks to Poynter, we got glimpses of a couple of softer paid-content options being tried out by GlobalPost and The Spokesman-Review of Spokane, Washington, Retin A images, that might be sprouting up soon elsewhere, too. The Lab's Megan Garber profiled one of the new companies offering that type of porous paywall, MediaPass, and All Things Digital's Peter Kafka sifted through survey results to try to divine what The New York Times' paywall might look like.

— Google's social media platform Google Wave officially died this week, a little more than a year after it was born. Tech pioneer Dave Winer looked at why it never took off and drew a few lessons, about Retin A, too.

— Finally, the Lab's Jonathan Stray took a look at some very cool things that The Guardian is doing with data journalism using free web-based tools. It's a great case study in a blossoming area of journalism.

Similar posts: Glucophage Dosage. Lipitor Mg. Glucophage No Rx. Effects of Lipitor. Where can i order Retin A without prescription. Flagyl photos.
Trackbacks from: Retin A Price. Retin A Price. Retin A Price. Retin A dose. Retin A cost. Buy Retin A from canada.

[This review was originally posted at the Nieman Journalism Lab Retin A Mg, on May 21, 2010.]

Should Facebook be regulated?: It's been almost a month since Facebook's expansion of Open Graph and Instant Personalization, and the concerns about the company's invasion of privacy continue to roll in. This week's appalling example of how much Facebook information is public comes courtesy of Openbook, a new site that uses Facebook's API to allow you to search all public Facebook updates. (Of course, you'll find similarly embarrassing revelations via a Twitter search, but the point is that many of these people don't know that what they're posting is public.)

We also got another anti-Facebook diatribe (two, Buy Retin A no prescription, actually) from a web luminary: Danah Boyd, the Microsoft researcher and social media expert. Boyd, who spends a lot of time talking to young people about social media, noted two observations in her first post: Many users' mental model of who can see their information doesn't match up with reality, and people have invested so much time and resources into Facebook that they feel trapped by its changes. In the second post, Boyd proposes that if Facebook is going to refer to itself as a "social utility" (and it's becoming a utility like water, Retin A blogs, power or the Internet, she argues), then it needs to be ready to be regulated like other utilities.

The social media blog Mashable has chimed in with a couple of defenses of Facebook (the web is all about sharing information; Facebook has normalized sharing in a way that users want to embrace), but the din has reached Facebook's ears. The Wall Street Journal reported that the issue has prompted deep disagreements and several days of discussions at Facebook headquarters, What is Retin A, and a Facebook spokesman said the company is going to simplify privacy controls soon.

Meanwhile, tech investor and entrepreneur Chris Dixon posited that Facebook is going to use its web-wide Like button to corner the market on online display ads, similar to the way Google did with text ads, Retin A Mg. Facebook also launched 0.facebook.com, a simple mobile-only site that's free on some carriers, leading Poynter's Steve Myers to wonder if it's going to become the default mobile web for feature, or "dumb" phones. But The New York Times argued that when it comes to social data, Facebook still can't hold a candle to the good old-fashioned open web, australia, uk, us, usa.

—

Are iPad apps worth it?: The iPad's sales haven't slowed down yet — it's been projected to outsell the Mac, and one in five Americans say they might get one — but there are still conflicting opinions over how deeply publishers should get involved with it. Slate Group head Jacob Weisberg was the latest to weigh in, arguing that iPad apps won't help magazines and newspapers like they think it will. Retin A Mg, He makes a couple of arguments we've seen several times over the past month or two: App producers are entering an Apple-controlled marketplace that's been characterized by censorship, and apps are retrograde attempts to replicate the print experience.

"They're claustrophobic walled gardens within Apple's walled garden, Buy Retin A without a prescription,  lacking the basic functionality we now expect with electronic journalism: the opportunity to comment, the integration of social media, the ability to select text and paste it elsewhere, and finally the most basic function of all: links to other sources," Weisberg says. GQ magazine didn't get off to a particularly encouraging start with its iPad offerings, selling just 365 copies of its $2.99 Men of the Year iPad issue, real brand Retin A online.

A few other folks are saying that the iPad is ushering in fundamental changes in the way we consume personal media: At Ars Technica, Forrester analyst Sarah Rotman Epps notes that the iPad is radically different from what people say they want in a PC, but they're still more than willing to buy it because it makes complex computing simple. (The term Forrester is using to describe the tablet era, curated computing, Retin A description, seems like a stretch, though.) Norwegian digital journalist John Einar Sandvand offers a similar take, saying that tablets' distinctive convenience will further weaken print newspapers' position. And the Lab's Josh Benton says the iPad could have an effect on the way we write, too, Retin A Mg.

—

Slipping through the Times' and WSJ's paywalls: New York Times editor Bill Keller gave an update late last week on the plans for his paper's much-anticipated paywall — he didn't tell us anything new, unless you count the news that the wall will start in January 2011, rather than just "next year." But in reiterating the fact that he wasn't breaking any news, he gave Media Matters' Joe Strupp a bit of a clearer picture about how loose the Times' metered model will be: "Those who mainly come to the website via search engines or links from blogs, Retin A treatment, and those who only come sporadically -- in short, the bulk of our traffic -- may never be asked to pay at all," Keller wrote.

In the meantime, digital media consultant Mark Potts found another leaky paywall at The Wall Street Journal. Fast shipping Retin A, Potts canceled his WSJ.com subscription (after 15 years!) and found that he's still able to access for free almost everything he had previously paid for with only a few URL changes and the most basic of Google skills. And even much of that information, he argues, is readily available from other sources for free, damaging the value of the venerable Journal paywall. "Even the Journal can't enforce the kind of exclusivity that would make it worth paying for—it's too easy to look elsewhere," Potts writes. Retin A Mg, Another Times-related story to note: The paper's managing editor for news, Jill Abramson, will leave her position for six months to become immersed in the digital side of the Times' operation. The New York Observer tries out a few possible explanations for the move, Retin A recreational.

—

Going all-in on digital publishing: Speaking of immersion, two publishers in the past two weeks have tried a fascinating experiment: Producing an issue entirely through new-media tools. The first was 48 Hours, a new San Francisco-based magazine that puts together each issue from beginning to end in two days. The magazine's editors announced a theme, Retin A pics,  solicited submissions via email and Twitter, received 1,500 submissions, then put together the magazine, all in 48 hours. Several who saw the finished product were fairly impressed, but CBS's lawyers were a little less pleased about the whole '48 Hours' name, Retin A Mg. Gizmodo had a Q&A with the mag's editors (all webzine vets) and PBS MediaShift and the BBC took a closer look at the editorial process.

Second, effects of Retin A, the Journal Register Co. newspaper chain finished the Ben Franklin Project, an experiment in producing a daily and weekly newspaper and website using only free, web-based tools. Two small Ohio newspapers accomplished the feat this week, Retin A dose, and Poynter's Mallary Jean Tenore took a look inside the effort. Retin A Mg, What she uncovered should be an inspiration for people looking to implement change in newsrooms, especially ones that might be resistant to digital media. A quote from the daily paper's managing editor sums it up: "When we started out, we said, 'We're going to do what. How are we going to do this?' Now we're showing ourselves that we can operate in a world that, even six months ago, used to be foreign to us."

—

Reading roundup: This week, Retin A pharmacy, I've got two developments and a handful of other pieces to think on:

— Yahoo bought the online content producer Associated Content for $100 million this week. News business analyst Ken Doctor examined what this deal means for Yahoo (it's big, he says), and considers the demand-and-advertising-driven model employed by Associated Content and others like Demand Media.

— If you follow NYU professor Jay Rosen on Twitter, Retin A online cod, you've heard a ton about fact-checking over the past couple of months. A couple more interesting tidbits on the subject this week: Fact-checks are consistently the AP's most popular pieces online, and Minnesota Public Radio has unveiled PoliGraph, its own fact-checking effort, Retin A Mg.

— Poynter's Rick Edmonds compares two of the more talked-about local news startups launching this summer, Washington D.C.'s TBD and Hawaii's Honolulu Civil Beat. He's got some great details on both. Poynter also put together a list of 200 moments over the last decade that transformed journalism.

— If you're up for a quick, deep thought, the Lab's Josh Benton muses on the need for news to structure and shrink its users' world. "I think it’s journalists who need to take up that challenge," he says, "to learn how to spin something coherent and absorbing and contained and in-the-moment and satisfying from the chaos of the world around us."

— And once you're done with that, head into the weekend laughing at the Onion's parody of newspapers' coverage of social media startups.

Similar posts: Zoloft Price. Tramadol Mg. Cephalexin Cost. Buy Lipitor without prescription. Is Armour safe. Purchase Lipitor online.
Trackbacks from: Retin A Mg. Retin A Mg. Retin A Mg. Retin A without a prescription. After Retin A. Online buying Retin A.

[This review was originally posted at the Nieman Journalism Lab Buy Flagyl No Prescription, on May 28, 2010.]

Facebook simplifies privacy control: After about a month of loud, sustained criticism, Facebook bowed to public pressure and instituted some changes Wednesday to users' privacy settings. The default status of most of the data on Facebook — that is, public —hasn't changed, but the social networking site did make it easier for users to determine and control their various privacy settings. For some social media critics, the tweaks were enough to close the book on this whole privacy brouhaha, Buy generic Flagyl, but others weren't so satisfied with Facebook. Here at the Lab, Megan Garber seized on the theme of "control" in Facebook's announcement, arguing that the company is acknowledging that online sharing is as much individual and self-interested as it is communal and selfless.

Before rolling out those changes, Facebook's Mark Zuckerberg penned a Washington Post op-ed that served as a defense of Facebook's privacy policy masquerading as an apology. "If we give people control over what they share, they will want to share more, Buy Flagyl No Prescription. If people share more, online Flagyl without a prescription, the world will become more open and connected," he wrote. The reaction was swift and negative: It was called "long on propaganda and short on news," "disingenuous" and "missing the point" by several media and tech critics.

Their comments were part of continued attacks on Facebook's privacy stance that began to shift from "Facebook is evil" to "So what do we do now?" Facebook's new, more private rivals escalated their efforts to provide an alternative, Flagyl over the counter, while social media researcher Danah Boyd argued that leaving Facebook would be futile and instead urged users to "challenge Facebook to live up to a higher standard." Several legal and web thinkers also discussed whether the government should regulate Facebook's privacy policies, and the Harvard Business Review's Bruce Nussbaum made the case that Facebook has alienated the generational principles of its primary user base of millennials. (Mathew Ingram of GigaOm disagreed.)

But amid all that, Facebook — or at least the sharing of personal information — got another defender: The prominent tech thinker Steven Johnson. In a thoughtful essay for Time, He used the example of media critic Jeff Jarvis' public bout with prostate cancer to argue that living in public has its virtues, too. "We have to learn how to break with that most elemental of parental commandments: Don't talk to strangers," Johnson wrote. Buy Flagyl No Prescription, "It turns out that strangers have a lot to give us that's worthwhile, and we to them." Of course, Johnson argues, being public or private is for the first time a decision, and it requires a new kind of literacy to go with it.

—

Paywalls and the links between old and new media: The Pew Research Center's Project for Excellence in Journalism released a study examining the way several big news topics were discussed across several online news platforms, Where can i buy cheapest Flagyl online, and as usual, it's a whole lot of discoveries to sift through. Among the headlines that Pew pointed out in its summary: Twitter users share more technology news than other platforms, the traditional press may be underemphasizing international news, blogs and the press have different news agendas, and Twitter is less tied to traditional media than blogs. (Mashable has another good roundup, online buy Flagyl without a prescription, focusing on the differences between the traditional media and the blogosphere.

The study did take some heat online: TBD's Steve Buttry took issue with the assertion that most original reporting comes from traditional journalists, and the Knight Digital Media Center's Amy Gahran dug into the study's methodology and argued that Pew selected from a list of blogs predisposed to discuss what the traditional media is reporting, and that Pew's definition of news is shaped by circular reasoning.

Gahran was looking at what turned out to be the most attention-grabbing statistic from the study: That 99 percent of the stories blogs link to are produced by the mainstream media, and more than 80 percent come from just four news outlets — the BBC, CNN, The New York Times and the Washington Post, Buy Flagyl No Prescription. DailyFinance media columnist Jeff Bercovici used that statistic to caution that the Times may be giving up a valuable place as one of the top drivers of online news discussion by implementing its paywall next year. Flagyl used for, Reuters' Felix Salmon echoed that warning, adding that if the Times is truly keeping the doors to its site open to bloggers, it should be trumpeting that as loudly as possible. And wouldn't you know it — the next day the Times did just that, reiterating that links to their site from blogs won't count against the limit of free visits.

Meanwhile, Rupert Murdoch's British newspaper the Times and Sunday Times unveiled plans for its soon-to-be-erected paywall, Flagyl price, coupon, including the fact that all of the sites' articles will be blocked from all search engines. Buy Flagyl No Prescription, The Times and New York Times' paywalls were almost tailor-made for being contrasted, and that's exactly what the Lab's Jason Fry did, using them as examples of an open vs. closed paradigm regarding paid content.

—

A challenger to the AP's model: We found out about a fascinating news innovation this week at the TechCrunch Disrupt Conference, where the online news sharing company Publish2 revealed News Exchange, its new content-sharing service for publishers. Flagyl maximum dosage, Essentially, News Exchange is a way for media outlets, both online-only and traditional, to send and receive stories to each other for publication while retaining control of what they share and with whom.

If that sounds like a free, open version of The Associated Press, it's because that's exactly what Publish2 sees it as, Flagyl duration. At the conference, Publish2's Scott Karp came out against The Associated Press with both guns blazing, calling it "a big enemy of newspapers" and "an obsolete, inefficient monopoly ripe for destruction." Publish2's goal, he said, is to "Craigslist the AP." (In a blog post, Publish2's Ryan Sholin went into some more detail about why and how.)

Publish2's bold idea was met with mixed reactions among both the tech and media crowds: A few of TechCrunch's panelists wondered whether print publications were worth building a business around, but they were impressed enough to advance it to the final round of the conference's startup competition anyhow, Buy Flagyl No Prescription. NYU j-prof Jay Rosen called it "an extension into print of 'do what you do best and link to the rest,'" and CUNY j-prof C.W. Anderson said he was thrilled to watch Publish2 take on an irrational system but concerned that the tangle of CMS's could trip it up. But media consultant Mark Potts noted that much of what the AP transmits is news it reports and produces, something Publish2 isn't going to try to do. Flagyl use, It's rare that we see such a bold, explicit attempt to take down such an established news organization, so this will doubtless be a project to keep a close eye on.

—

A disappointing iPad app and an open-web debate: A couple of iPad-related developments and debates this week: While publishers cautiously awaited Buy Flagyl No Prescription, the iPad's international release this week, Wired magazine released its iPad app this week — an eagerly awaited app in tech circles. The app is $5 per month, significantly more than the $10 per year that the magazine charges subscribers. Gizmodo Australia's John Herrman called it "unequivocally, the best magazine for the iPad, online Flagyl without a prescription," but still wasn't entirely impressed. It's too expensive, takes up too much space, and doesn't deliver the reinvention of the magazine that we were expecting, he said. Flagyl photos, Lost Remote's Steve Safran was harsher — calling it a magazine dropped into an app. "Simply taking your existing magazine and sticking in some video does not make it a more attractive offering; it makes it a website from 2003," he said.

The New York Times Magazine's Virginia Heffernan ruffled a few feathers this week with a short essay on "The Death of the Open Web," in which she compared the move into the carefully controlled environs of Apple's products like the iPhone and iPad to white flight, Buy Flagyl No Prescription. Web writers Stowe Boyd and Tim Maly refuted Heffernan's argument, pointing primarily to the iPhone and iPad's browser and arguing that it keeps the door open to virtually everything the web has to offer. And blogging pioneer Dave Winer said the phrase "death of the open web" is rendered meaningless by the fact that it can't be verified. In a final quick iPad note, the journalism and programming site Hacks/Hackers hosted a conference in which attendees built an impressive 12 iPad apps in 30 hours, after Flagyl.

—

Reading roundup: This week, we've got two news items and a handful of other thoughtful or helpful pieces to take a look at. Buy Flagyl No Prescription, — The Bay Citizen, a nonprofit local news site based in San Francisco, launched this week. The San Francisco Bay Guardian took a look at the challenges in front of the Bay Citizen, Poynter used it as a lens to view four trends among news startups, and the Chicago Reader examined the Chicago News Cooperative, Purchase Flagyl online no prescription, another nonprofit news startup that also provides stories to The New York Times. The Lab's Laura McGann also gave some tips for launching a news site the right way.

— Forbes bought the personal publishing site True/Slant, whose founder, Lewis Dvorkin, is a former Forbes staffer. Dvorkinexplained his decision to sell, and Felix Salmon expressed his skepticism about True/Slant's future.

— Longtime journalists Tom Foremski and Caitlin Kelly both wrote thoughtful posts on what happens when pageviews become a high priority within news organizations, Buy Flagyl No Prescription. They're not optimistic.

— Two pieces to bookmark for future reference: Mashable has a thorough but digestible overview of five ways to make money off of news online, and TBD's Steve Buttry gives some fantastic tips for landing a job in digital journalism.

— Finally, NewsCred's Shafqat Islam has a wonderful guide to creating effective topic pages for news. This one should be a must-read for any news org looking seriously at context-driven news online.

Similar posts: Buy Glucophage No Prescription. Tramadol No Rx. Order Cipro. Cipro pictures. Tramadol pharmacy. Buy cheap Armour no rx.
Trackbacks from: Buy Flagyl No Prescription. Buy Flagyl No Prescription. Buy Flagyl No Prescription. Where can i order Flagyl without prescription. Flagyl reviews. Online buying Flagyl.